Ticker Short Interest

OMDA Short Interest Intelligence

Omada Health, Inc. Common Stock positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Squeeze Pressure

Squeeze Pressure

Covering Rally

OMDA is classified as Squeeze Pressure. Latest reported short interest is 7.8M shares; short interest changed -0.0%, price moved +21.9% since the previous report, short interest is in the 86th percentile, and days to cover is in the 71th percentile. Trend context is constructive.

Setup Score72/100Squeeze Pressure
Reported Short Interest7.8M-0.0% vs prior report
Days To Cover6.4871.43 percentile
Price Reaction+21.9%since previous short report
Squeeze Pressure72crowding, trend, and pressure
Bearish Conviction33shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

72

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

33

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

79

Latest short interest is 7.8M shares and days to cover is 6.48.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

OMDA Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 7791330 7793989 0.0% 6.48 1201972
15 Jun 2026 7793989 6992007 11.5% 7.77 1002715
29 May 2026 6992007 6079722 15.0% 7.80 896310
15 May 2026 6079722 4218961 44.1% 3.72 1633102
30 Apr 2026 4218961 3657694 15.3% 5.75 733536
15 Apr 2026 3657694 3541079 3.3% 5.47 669224
31 Mar 2026 3541079 2843612 24.5% 2.51 1411464

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.